4//SEC Filing
KEEFE MICHELLE 4
Accession 0001209191-23-012784
CIK 0001610950other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:05 PM ET
Size
10.3 KB
Accession
0001209191-23-012784
Insider Transaction Report
Form 4
KEEFE MICHELLE
Pres., Commercial Solutions
Transactions
- Award
Class A Common Stock
2023-02-23+1,203→ 196,676 total - Tax Payment
Class A Common Stock
2023-02-23$38.25/sh−3,338$127,679→ 196,709 total - Award
Class A Common Stock
2023-02-23+4,627→ 195,473 total - Award
Class A Common Stock
2023-02-23+3,371→ 200,047 total
Footnotes (3)
- [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022.
- [F2]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
- [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment.
Documents
Issuer
Syneos Health, Inc.
CIK 0001610950
Entity typeother
Related Parties
1- filerCIK 0001766036
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:05 PM ET
- Size
- 10.3 KB